Artículo
Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry
Autor/es | Vitorica Ferrández, Francisco Javier
González Domínguez, Raúl García Barrera, Tamara Gómez Ariza, José Luis |
Departamento | Universidad de Sevilla. Departamento de Bioquímica y Biología Molecular |
Fecha de publicación | 2015-01-05 |
Fecha de depósito | 2023-07-06 |
Publicado en |
|
Resumen | The identification of pathological mechanisms underlying to Alzheimer's disease is of great
importance for the discovery of potential markers for diagnosis and disease monitoring. In this study,
we investigated regional ... The identification of pathological mechanisms underlying to Alzheimer's disease is of great importance for the discovery of potential markers for diagnosis and disease monitoring. In this study, we investigated regional metabolic alterations in brain from the APP/PS1 mice, a transgenic model that reproduces well some of the neuropathological and cognitive deficits observed in human Alzheimer's disease. For this purpose, hippocampus, cortex, cerebellum and olfactory bulbs were analyzed using a high-throughput metabolomic approach based on direct infusion mass spectrometry. Metabolic fingerprints showed significant differences between transgenic and wild-type mice in all brain tissues, being hippocampus and cortex the most affected regions. Alterations in numerous metabolites were detected including phospholipids, fatty acids, purine and pyrimidine metabolites, acylcarnitines, sterols and amino acids, among others. Furthermore, metabolic pathway analysis revealed important alterations in homeostasis of lipids, energy management, and metabolism of amino acids and nucleotides. Therefore, these findings demonstrate the potential of metabolomic screening and the use of transgenic models for understanding pathogenesis of Alzheimer's disease. |
Agencias financiadoras | Ministerio de Ciencia e Innovación (MICIN). España Junta de Andalucía |
Identificador del proyecto | CTM2012-38720-C03-01
P008-FQM-3554 P009-FQM-4659 |
Cita | Vitorica Ferrández, F.J., González Domínguez, R., García Barrera, T. y Gómez Ariza, J.L. (2015). Metabolomic screening of regional brain alterations in the APP/PS1 transgenic model of Alzheimer's disease by direct infusion mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis, 102, 425-435. https://doi.org/10.1016/j.jpba.2014.10.009. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
Metabolomic_screening_of_ ... | 883.0Kb | [PDF] | Ver/ | Artículo |
Este registro aparece en las siguientes colecciones
Este documento está protegido por los derechos de propiedad intelectual e industrial. Sin perjuicio de las exenciones legales existentes, queda prohibida su reproducción, distribución, comunicación pública o transformación sin la autorización del titular de los derechos, a menos que se indique lo contrario.